Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Among women with ductal carcinoma in situ (DCIS) treated between 1978 and 2016 at Memorial Sloan Kettering Cancer Center (MSK) in New York City, Black women had a significantly higher rate of 10-year local recurrence (LR) following breast-conserving surgery (BCS) overall and after receiving radiotherapy (RT) compared with Asian, Hispanic, and White women, according to a spotlight presentation on day 1 of the San Antonio Breast Cancer Symposium.
“Differences in outcomes of patients with DCIS by ethnicity and race have not been well studied,” presenting author Natalia Polidorio, MD, PhD, a clinical research fellow in MSK’s Department of Surgery said. “We aimed to compare LR rates in women with DCIS treated with BCS across racial and ethnic groups."
Of the 4207 cases included in this retrospective analysis, 9% were Black women vs 80% White women, 6% Asian women, and 5% Hispanic Women. Their median (IQR) age was 57 (49-67) years, the median follow-up was 8.8 years, 56% received RT, and 26% received endocrine therapy. There were 602 LR events, 52% of which were DCIS and 47% invasive disease. The 10-year LR rate was 15%, or 11% among those who received RT vs 20% (P < .001) among those who did not receive RT.
The Black women were older (P < .001), had more clinical presentation (P = .006), and together with Hispanic women were more likely to require 3 or more excisions (P = .006). They also accounted for the highest cumulative incidence of LR, at 25%, compared with 15% of Hispanic, 14% of White, and 11% of Asian women. Even when accounting for receipt (P = .04) or not (P = .3) of RT, respectively, Black women still had the highest rates of LR (31% and 21%) vs Hispanic (25% and 9%), White (19% and 11%), and Asian (13% and 9%) women.
Even after multivariate analysis, using White women as a reference, Black women with DCIS had a 48% higher risk of LR after BCS (HR, 1.48, 95% CI, 1.12-1.96; P = .01) vs a 7% higher risk among Hispanic women (HR, 1.07; 95% CI, 0.73-1.58) and a 29% reduced risk among Asian women (HR, 0.71; 95% CI, 0.47-1.07).
Breaking these data down, most (78%) of the Black women in this analysis were aged 50 to 79 years vs 61% of Asian, 65% of Hispanic, and 70% of White women. Fifteen percent had clinical presentation vs 13% of Asian, 11% of Hispanic, and 9.7% of White women. Eighteen percent had margins of less than 2 mm vs 14% of Asian, 12% of Hispanic, and 16% of White women, and 82% had margins of 2 mm or more vs 86%, 88%, and 84%, respectively. Further, they had the lowest rate of radiological presentation, at 85% vs 87%, 89%, and 89.3%.
Univariate analysis, too, showed a higher overall risk of LR among Black women (HR, 1.43; 95% CI, 1.09-1.87; P = .04) compared with Hispanic (HR, 1.08; 95% CI, 0.74-1.57) and Asian women (HR, 0.77; 95% CI, 0.52-1.14). Factors in this analysis associated with a lower risk of LR were younger (50 -79 years) vs older (80 years and older) age (0.71; 95% CI, 0.60-0.85; P < .001), having a year of diagnosis of 1999 or later (HR, 0.77, 95% CI, 0.65-0.92; P = .005), having low-/intermediate-grade disease (HR, 0.92; 95% CI, 0.77-1.09; P = .3), having margins of 2 mm or more (HR, 0.65; 95% CI, 0.53-0.80; P < .001), receiving endocrine therapy (0.46; 95% CI, 0.37-0.58; P < .001), and receipt of RT (HR, 059; 95% CI, 0.50-0.69; P < .001).
The higher risk of LR among Black women with DCIS following BCS was also seen despite the following:
No associations were seen with family history, grade, necrosis, or number of excisions.
The conclusions from this research are that despite adjusting for known clinicopathologic and treatment risk factors, Black women with DCIS still had a significantly higher rate of LR even after BCS. Because of this, the authors recommended when making decisions regarding adjuvant therapy, clinicians need to consider these differences.
Reference
Polidorio N, Jones VM, Sevilimedu V, et al. Impact of race and ethnicity on recurrence risk in patients with ductal carcinoma in situ treated with breast-conserving surgery. Poster presented at: San Antonio Breast Cancer Symposium; December 5-9, 2023; San Antonio, TX. Poster: PS01-07.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen